About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 21 Issue 2 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1994 results:

Case report

Influenza A virus infection is associated with systemic capillary leak syndrome: case report and systematic review of the literature

Adrian Sousa, Oscar Len, Laura Escolà-Vergé, Bruno Magnifico, Chema Mora, Elisabeth Papiol, Eva Revilla, Benito Almirante

Antiviral Therapy 2016; 21:181-183

Case report

Virological failure in two patients with HIV-1 RNA viral loads >1,000,000 copies/ml initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate

Jessica L Adams, Dana Byrne, Rosalie Pepe, Anastasia Gray, John D Baxter

Antiviral Therapy 2016; 21:175-180

Case report

Acute viral hepatitis presenting as cytomegalovirus, hepatitis E and Epstein–Barr virus IgM antibody positive

Qin Huang, Xin-Hua Li, Cuiyun Zhu, Jingjing Yan, Zhigang Song, Shuye Zhang, Yunwen Hu, Liang Chen, Yun Ling

Antiviral Therapy 2016; 21:171-173

Original article

Intracellular expression of an anti-idiotypic antibody single-chain variable fragment reduces porcine reproductive and respiratory syndrome virus infection in MARC-145 cells

Qiongyi Li, Xiangpeng Wang, Chengbao Wang, Ying Yu, Gang Wang, Jiming Gao, Hongliang Liu, Huali Xie, Baicheng Huang, Zhijun Li, Ning Kong, Gaiping Zhang, Walter H Hsu, En-Min Zhou

Antiviral Therapy 2016; 21:161-170

Original article

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy

Clara TMM de Kanter, Maria Buti, Ralph DeMasi, Sivi Ouwerkerk-Mahadevan, Anton SM Dofferhoff, James Witek, Joost PH Drenth, Stefan Zeuzem, David M Burger

Antiviral Therapy 2016; 21:153-159

Original article

Pharmacokinetic drug–drug interaction study between raltegravir and citalopram

Maren I Blonk, Charlotte CA Langemeijer, Angela PH Colbers, Karin EJ Hoogtanders, Ron HN van Schaik, Bas JJW Schouwenberg, David M Burger

Antiviral Therapy 2016; 21:143-152

Original article

T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo study

Camilla Tincati, Alessia Savoldi, E Stefania Cannizzo, Giusi M Bellistrì, Roberta Termini, Marzia Garau, Daniela Mancusi, Antonella d’Arminio Monforte, Giulia Marchetti

Antiviral Therapy 2016; 21:133-142

Original article

The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirin

Marianne Martinello, Ana Schteinman, Maryam Alavi, Kenneth Williams, Gregory J Dore, Richard Day, Gail V Matthews

Antiviral Therapy 2016; 21:127-132

Original article

Vitamin D deficiency is common in HIV-infected southern Australian adults

Karen M Klassen, Christopher K Fairley, Michael G Kimlin, Jane Hocking, Liza Kelsall, Peter R Ebeling

Antiviral Therapy 2016; 21:117-125

Original article

The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial

Donald P Kotler, Qing He, Ellen S Engelson, Jeanine B Albu, Marshall J Glesby

Antiviral Therapy 2016; 21:107-116

Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.